Novartis | NOVN - Credores Comerciais

Preço das Ações
115.90
Mudança Diária
2.56 2.26%
Mensal
-4.10%
Anual
23.02%
Q2 Previsão
111.47




Credores Comerciais Alterar Data
AbbVie USD 3.59B 28.65B 2025-12
Alcon AG USD 926M 31M 2025-12
Almirall EUR 258.05M 58.66M 2025-12
Amgen USD 20.89B 1.25B 2025-12
AstraZeneca USD 22.51B 2.78B 2026-03
Autolus Therapeutics Ltd USD 3.08M 7.88M 2025-12
Bayer EUR 7.08B 700M 2025-12
Biogen USD 358.5M 73.5M 2026-03
Bristol-Myers Squibb USD 4.23B 659M 2026-03
Eli Lilly USD 5.03B 350M 2026-03
Fresenius EUR 1.08B 65M 2025-09
Fresenius Medical Care EUR 835.55M 109.7M 2025-12
Galapagos EUR 104.65M 4.02M 2025-12
Genmab DKK 6M 2M 2025-09
Gilead Sciences USD 715M 93M 2025-12
GlaxoSmithKline GBP 14.34B 1.05B 2026-03
GRIFOLS EUR 841M 37.68M 2025-12
Hikma Pharmaceutical USD 715M 104M 2025-12
J&J USD 10.46B 1.53B 2026-03
Lonza CHF 471M 3M 2024-12
Merck EUR 2.11B 182M 2025-12
Merck USD 4.4B 257M 2025-12
Novartis USD 4.46B 99M 2025-12
Novartis USD 4.46B 99M 2025-12
Novo Nordisk DKK 19.76B 4.15B 2025-12
Orion EUR 150.3M 26.8M 2026-03
Pfizer USD 5.02B 142M 2025-09
Philips EUR 1.93B 214M 2025-12
Recordati EUR 315.05M 15.17M 2025-09
Regeneron Pharmaceuticals USD 1.03B 4.81B 2026-03
Roche Holding CHF 5.78B 1.27B 2025-12
Sanofi EUR 22.71B 219M 2026-03
UCB EUR 4.04B 755M 2025-12